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The coronavirus nucleocapsid (N) protein is a major structural component of virions that associates with the genomic RNA
to form a helical nucleocapsid. N appears to be a multifunctional protein since data also suggest that the protein may be
involved in viral RNA replication and translation. All of these functions presumably involve interactions between N and viral
RNAs. As a step toward understanding how N interacts with viral RNAs, we mapped high-efficiency N-binding sites within
BCV- and MHV-defective genomes. Both in vivo and in vitro assays were used to study binding of BCV and MHV N proteins
to viral and nonviral RNAs. N–viral RNA complexes were detected in bovine coronavirus (BCV)-infected cells and in cells
transiently expressing the N protein. Filter binding was used to map N-binding sites within Drep, a BCV-defective genome that
is replicated and packaged in the presence of helper virus. One high-efficiency N-binding site was identified between
nucleotides 1441 and 1875 at the 39 end of the N ORF within Drep. For comparative purposes N-binding sites were also
mapped for the mouse hepatitis coronavirus (MHV)-defective interfering (DI) RNA MIDI-C. Binding efficiencies similar to
those for Drep were measured for RNA transcripts of a region encompassing the MHV packaging signal (nts 3949–4524), as
well as a region at the 39 end of the MHV N ORF (nts 4837–5197) within MIDI-C. Binding to the full-length MIDI-C transcript
(;5500 nts) and to an ;1-kb transcript from the gene 1a region (nts 935–1986) of MIDI-C that excluded the packaging signal
were both significantly higher than that measured for the smaller transcripts. This is the first identification of N-binding
sequences for BCV. It is also the first report to demonstrate that N interacts in vitro with sequences other than the packaging
signal and leader within the MHV genome. The data clearly demonstrate that N binds coronavirus RNAs more efficiently than
nonviral RNAs. The results have implications with regard to the multifunctional role of N. © 2000 Academic PressINTRODUCTION
The coronavirus genome is a single-stranded, posi-
tive-sense, 27- to 32-kb RNA molecule, the largest
among all RNA viruses. The genomic RNA is encapsi-
dated by multiple copies of the nucleocapsid (N) protein
and is packaged as a helical nucleocapsid in the mature
enveloped virion (Kennedy and Johnson-Lussenburg,
1975; Macneughton and Davies, 1978; Caul et al., 1979;
avies et al., 1981). Recently it was suggested that coro-
aviruses contain a more structured, possibly icosahe-
ral, core consisting of the membrane (M) and N proteins
urrounding a helical nucleocapsid (Risco et al., 1996).
All coronavirus N proteins are 50- to 60-kDa phospho-
proteins, with an overall high basic amino acid content.
Within any antigenic subgroup the amino acid sequence
homology is high, whereas the proteins are highly diver-
gent across the different antigenic subgroups (Lapps et
al., 1987). Three structural domains are present in the N
protein (Parker and Masters, 1990). The middle domain is
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235responsible for RNA binding (Masters, 1992; Nelson and
Stohlman, 1993; Nelson et al., 2000). During a normal
infection, N is one of the most abundantly expressed
viral proteins, expressed at a much higher level than any
of the viral replication factors that are expected to inter-
act with viral RNAs.
Other functions, in addition to its known structural role,
have been postulated for N. Data suggest that N may be
involved in viral transcription (Compton et al., 1987; Baric
et al., 1988) and translation control (Tahara et al., 1994).
MHV N colocalizes with putative replicase proteins in
virus-infected cells, providing further support that N may
be involved in RNA replication (van der Meer et al., 1999;
Denison et al., 1999). It was recently demonstrated that N
interacts with heterogeneous nuclear ribonucleoprotein
A1 (hnRNP-A1), both in vitro and in vivo (Wang and
Zhang, 1999). Cellular hnRNP-A1 binds to MHV negative-
strand leader and intergenic sequences (Li et al., 1997).
It has been postulated that hnRNP plays a role in MHV
transcription (Zhang and Lai, 1995).
In this study we analyzed N–RNA interactions to begin
addressing the mechanism by which N recognizes viral
RNAs. Multiple assays were used to gain insight into
N–RNA interactions that may be involved in coronavirus
RNA packaging, nucleocapsid assembly, and other pos-
tulated functions of N. Quantitative analysis of N–RNA
interactions revealed that N interacts more efficiently
0042-6822/00 $35.00
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236 COLOGNA, SPAGNOLO, AND HOGUEwith coronavirus RNA than with noncoronavirus RNA.
High-efficiency binding regions were mapped for the
BCV-defective genome RNA Drep and defective interfer-
ing (DI) MHV RNA MIDI-C (de Groot et al., 1992; Chang et
al., 1994) (Fig. 1). Both defective genomes are replicated
and packaged by their parental virus. BCV and MHV
belong to the same antigenic subgroup. Sequence com-
parisons indicate that the two viruses are closely related
(Lapps et al., 1987; Abraham et al., 1990a,b; Kienzle et al.,
1990). Even though the two viruses share many similar-
ities, they appear to differ with regard to RNA packaging.
BCV packages subgenomic RNA in addition to genomic
RNA (Hofmann et al., 1990), whereas MHV packages
very little, if any, of its subgenomics. BCV Drep is repli-
cated and packaged by BCV, but it does not contain any
gene 1b sequence (Fig. 1) (Chang et al., 1994; Cologna
and Hogue, 2000). MIDI-C contains part of gene 1b
where a packaging signal maps (van der Most et al.,
1991; Fosmire et al., 1992) (Fig. 1). We recently identified
a packaging signal in the BCV genome that is homolo-
gous to the MHV packaging signal (Cologna and Hogue,
2000). Our analyses of N-binding sites within the BCV
and MHV defective genomes provide the most compre-
FIG. 1. Schematic of two coronavirus-defective genomes and chi-
meric RNAs used to test the ability of the high-efficiency N-binding site
to function as a packaging signal. (A) Drep is a cloned BCV-defective
RNA (Chang et al., 1994) and pMIDI-C is a cloned MHV-A59 DI (van der
ost et al., 1991). The various parts of the genome that are included in
ach defective genome are labeled. Drep includes a 30-nt reporter
equence (T) derived from the TGEV N gene (Chang et al., 1994). The
pproximate position of the packaging signal (P) within the BCV and
HV genomes, as well as MIDI-C, is indicated. (B) Chimeric RNAs
ere made from coronavirus sequences (Drep, BCVN39, and BCVpkg)
loned at the 59 end of a cassette that contains the CAT gene, the
epatitis delta virus ribozyme (r), and the T7 terminator (T7t).hensive and comparative study to date of coronavirus
N–RNA interactions.
t
lRESULTS
BCV N–RNA complexes are present in virus-infected
cells
When we began our investigation to understand how
coronavirus RNAs are recognized by the N protein, our
main focus was directed at the identification of a pack-
aging signal for the bovine coronavirus-defective RNA
Drep (Chang et al., 1994). We hypothesized at the time,
ased on data from other studies in our lab, that Drep
ight contain a packaging signal within its N open read-
ng frame (ORF).
Identification of a packaging signal within Drep by
eletion mapping was not possible because of technical
imitations. Drep replication is readily compromised by
nly small deletions or point mutations (Chang and Brian,
996; Cologna and Hogue, unpublished data). Therefore,
oward our goal to identify a packaging signal for Drep,
e initially assayed for N–viral RNA interactions using
our different approaches. The rationale was that identi-
ication of N-binding sites on the Drep RNA could give us
nsight toward what interactions are important for Drep
ackaging.
We first determined which viral RNAs interact with N
uring a BCV infection. Mock- and BCV-infected HCT
ells were metabolically labeled with [32P]orthophos-
hate in the absence of actinomycin D. Both viral and
ellular RNAs are labeled in the absence of the inhib-
tor, whereas only viral RNAs are labeled in the pres-
nce of the inhibitor. Cytoplasmic RNAs were either
xamined directly or after immunoprecipitation with
ntibodies specific for the N protein. Antibodies
gainst the spike protein (S) or preimmune sera were
sed as controls. As expected, in the absence of
ctinomycin D a large amount of label was incorpo-
ated into ribosomal RNAs (Fig. 2A, lanes 1 and 2).
eaker viral RNA signals were observed over the
ackground when total RNA from infected cells was
nalyzed directly (Fig. 2A, lane 2). Genomic and sub-
enomic RNAs were clearly visible from BCV-infected
ells labeled in the presence of actinomycin D,
hereas no RNAs were seen with mock-infected cells
Fig. 2A, lanes 3 and 4). A profile typical of virus
enomic and subgenomic RNAs was observed for
NAs coimmunoprecipitated with antibodies against
(Fig. 2A, lanes 5 and 6). Immunoprecipitation with
he BCV S-specific antibodies demonstrated that the
–RNA complexes were specific for the N protein and
hat we were not merely recovering translation com-
lexes. In all experiments, specific immunoprecipita-
ion of the N and S proteins was verified by SDS–
AGE/Western blotting analysis (data not shown).
The coprecipitated RNAs from cells labeled in the
bsence of actinomycin D comigrated with viral RNAshat were labeled and analyzed directly from cells
abeled in the presence of actinomycin D (Fig. 2A,
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237CORONAVIRUS N–RNA INTERACTIONScompare lanes 4 and 6). No RNAs were recovered
using control sera (Fig. 2A, lanes 7–10). Therefore, the
coimmunoprecipitated RNAs were assumed to be viral
RNAs. To support this assumption, unlabeled N–RNA
complexes were isolated and Northern blots were
probed with a BCV N ORF-specific probe that recog-
nizes genomic and all subgenomic RNAs. Genomic
and subgenomic RNAs were readily detected in the
total RNA fractions (Fig. 2B, lane 12) and in the N–RNA
complexes isolated by immunoprecipitation from the
same lysate (Fig. 2B, lane 14), but not from mock-
infected cell lysates (Fig. 2B, lanes 11 and 13). No
RNAs were coimmunoprecipitated with preimmune se-
rum (Fig. 2B, lane 15).
These results demonstrated for the first time that N
interacts with all viral RNAs during a BCV infection. Since
N–RNA complexes were isolated from cells labeled in
the absence of actinomycin D, the results suggest that
the N–viral RNA interactions are specific. Although we
cannot rule out the possibility that weakly labeled cellu-
FIG. 2. Metabolic labeling and Northern blot analyses of BCV spe-
cific N–RNA complexes. (A) HCT cells were infected with BCV or
mock-infected. Viral RNAs were labeled with [32P]orthophosphate in the
resence (lanes 3 and 4) or absence (lanes 1 and 2, 5–10) of actino-
ycin D. RNAs were analyzed directly (lanes 1–4) or after immunopre-
ipitation (lanes 5–10). Protein–RNA complexes were immunoprecipi-
ated with anti-N (lanes 5 and 6) polyclonal antibodies, the preimmune
erum (lanes 7 and 8) or anti-S ascites (lanes 9 and 10). (B) Unlabeled
NAs were isolated and run in parallel. Viral RNAs from total cytoplas-
ic RNA (lanes 11 and 12) and immunocomplexes using the anti-N
lanes 13 and 14) polyclonal antibodies and the preimmune serum (lane
5) were detected with a [32P]-labeled N gene-specific riboprobe.lar RNAs comigrated with the viral RNAs, no prominently
labeled cellular RNAs appeared to be associated with N.BCV N binds coronavirus RNA more efficiently than
noncoronavirus RNA
An in-solution binding assay (Geigenmuller-Gnirke et
al., 1993) was used as a second approach to analyze
N–RNA interactions and further address the question of
specificity. In this assay in vitro generated, unlabeled N
nd Drep RNA transcripts were incubated with in vitro
ranslated [35S]methionine-labeled BCV N protein. Pro-
ein–RNA interactions were measured by comigration of
35S]-labeled N protein with unlabeled RNA. When no
NA was included in the reaction mix, N protein did not
nter the agarose gel (Fig. 3, lane 1). A twofold molar
xcess of total cytoplasmic BHK RNA was included as a
ompetitor in reactions (Fig. 3, lanes 2–7). N protein
nteracted weakly with both 18S and 28S ribosomal
NAs when only BHK RNA was included in reactions
Fig. 3, lane 2). However, when coronavirus-specific tran-
cripts Drep and N were included, N protein appeared to
referentially bind the coronavirus RNAs over the ribo-
omal RNA (Fig. 3, compare lanes 2–4).
Influenza virus neuraminidase (NA) gene transcripts
ere also examined to further assess what appeared to
e preferential binding to coronavirus RNA. The full-
ength transcript is comparable in size and nucleotide
ontent to the BCV N gene. N protein did bind NA
ranscript (Fig. 3, lane 7). Since the signal was distorted
y comigration of full-length NA RNA with 18S ribosomal
NA, shorter NA transcripts were examined to more
learly assess N-binding to the NA RNA (Fig. 3, lanes 5
nd 6). Binding to the NA RNA was less than half of that
FIG. 3. Detection of BCV N–RNA interactions by an in-solution bind-
ing assay. A 1-mg sample of unlabeled Drep (lane 3) and equal molar
amounts of each of the other RNAs (N [lane 4], NA BamH1 [lane 5], NA
Spe1 [lane 6], and full-length NA [lane 7]) were incubated with in vitro
translated, [35S]-labeled BCV N protein. RNAs are visualized by the
comigration of the labeled N protein with unlabeled RNAs (lanes 3–7).
A 5-mg sample (;2.2 M excess) of BHK total cytoplasmic RNA were
included as a competitor in all reactions (lanes 2–7), except the reac-
tion containing no RNA (lane 1).
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238 COLOGNA, SPAGNOLO, AND HOGUEmeasured for a comparable molar amount of N RNA (Fig.
3, lanes 3–6). The results provided further direct data that
N interacts with coronavirus RNAs and suggested that
the protein binds viral RNAs more efficiently than non-
coronavirus RNAs.
To determine whether BCV N protein interacts with the
N gene when expressed in the absence of a coronavirus
infection, a third approach was used. BCV N and influ-
enza virus NA genes were expressed using vTF7-3, the
vaccinia virus recombinant that expresses T7 RNA poly-
merase (Fuerst et al., 1986). Following infection with
vTF7-3, BHK cells were transfected with plasmids that
contained the BCV N gene or the influenza virus NA
gene, singly and together (Fig. 4). At 16 h posttransfec-
tion cytoplasmic RNAs were analyzed either directly
(Figs. 4A and 4B, lanes 1–3) or after immunoprecipitation
with purified N-specific antibodies (Figs. 4A and 4B,
FIG. 4. Isolation of N–RNA complexes from cells transiently express-
ing BCV N. vTF7-3-infected BHK cells were transfected with plasmids
containing a cDNA copy of the N gene (pN.R1.1), the influenza NA gene
(pNA.R1), or cotransfected with both plasmids. RNAs were divided in
half and run on parallel denaturing agarose gels for Northern blotting
using equal amounts of either a BCV N gene-specific riboprobe (A) or
an influenza NA gene-specific riboprobe (B). Total cytoplasmic RNA
from transfected cells was analyzed directly (lanes 1–3) or after immu-
noprecipitation with anti-N (lanes 4–6) or anti-NA (lanes 7–9) polyclonal
sera. Right panels (lanes 4–9) were exposed eight times longer than
the left panels.lanes 4–6) or antibodies against NA (Figs. 4A and 4B,
lanes 7–9). RNAs were run on parallel agarose gels and
a
Ranalyzed by Northern blotting using BCV N-specific (Fig.
4A) or NA-specific (Fig. 4B) 32P-labeled riboprobes.
N-specific transcripts were present in cells trans-
ected with the N gene plasmid (Fig. 4A, lanes 1 and 3),
ut not in vTF7-3-infected cells transfected with only the
A gene plasmid (Fig. 4A, lane 2). N–RNA complexes
ere coimmunoprecipitated from cells transfected with
he N plasmid alone (Fig. 4A, lane 4) and from cells
otransfected with both N and NA plasmids (Fig. 4A, lane
, 83 exposure). No N transcripts were coprecipitated
hen only the NA gene was expressed (Fig. 4A, lane 5).
he amount of N transcripts from cells transfected with
nly the N gene was always higher than when the N and
A plasmids were coexpressed. Transfection optimiza-
ion experiments did not correct the disparity, which may
xplain in part the reason for the significant decrease in
he amount of N–N RNA complexes that were recovered
n the presence of NA RNA expression.
Using the NA gene-specific riboprobe NA transcripts
ere detected when the NA plasmid was transfected
lone or in combination with N plasmid, but not when the
atter was transfected alone (Fig. 4B, lanes 1–3). No
–NA RNA complexes were immunoprecipitated with
ntibodies against the NA protein (Fig. 4B, lanes 7–9),
gain indicating that our buffer conditions disrupted
ranslation complexes. However, a very small amount of
A–RNA complex was detected when the coexpressed
and NA genes were immunoprecipitated with the N
ntibodies (Fig. 4B, lane 6, 83 exposure).
The results were consistent with those from the in-
olution experiments. Absolute specificity of N–viral RNA
nteractions was not observed. However, N interacted
ore efficiently with its own ORF.
To determine whether the N protein interacts in trans
ith Drep RNA, we coexpressed both using the vaccinia
7 expression system as described above. Drep RNA
xpressed alone was immunoprecipitated with antibod-
es against N (data not shown). Drep contains an ORF
onsisting of a fusion between the amino-terminal por-
ion of gene 1a and the entire N ORF (Chang et al., 1994).
he N portion of the Pol-N fusion protein apparently
etains its RNA-binding function since Drep RNA-con-
aining complexes were immunoprecipitated with N an-
ibodies. The Pol-N fusion ORF is translated in vitro and
mmunoprecipitated with N-specific antibodies (Chang
nd Brian, 1996); therefore, expression of the Pol-N fu-
ion protein made it impossible to definitively demon-
trate interactions between N and Drep with this assay.
apping N-binding sites by filter binding
After establishing that N appeared to interact better
ith its viral RNAs than with noncoronavirus RNAs, we
eveloped a nitrocellulose filter-binding assay to map
nd characterize the interactions of N with viral-specific
NA in a quantitative manner. This assay also allowed
w
f
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239CORONAVIRUS N–RNA INTERACTIONSus to look more closely at specificity. The reaction con-
ditions were initially established using purified histidine
(his)-tagged BCV N protein that had been expressed in
bacteria. We previously reported our preliminary results
using the his-tagged N, which demonstrated that N binds
Drep, MHV DI MIDI-C, and a transcript that contained the
MHV packaging signal more efficiently than a noncoro-
navirus RNA (Cologna and Hogue, 1998).
To directly demonstrate that the his-tagged N protein
was binding to the Drep, MIDI-C, and MHV packaging
signal RNAs, UV crosslinking was performed following
incubation of filter-binding reactions. After RNase A di-
gestion covalently crosslinked proteins were analyzed by
SDS–PAGE. A protein corresponding to the expected
molecular mass of ;50 kDa for N crosslinked to equiv-
alent molar amounts of all the coronavirus RNAs, includ-
ing a 266-nt leader-containing RNA from the 59 end of the
BCV genome (Fig. 5A, lower arrow, lanes 2–7). Two
slower migrating species were also strongly crosslinked
to the RNAs (Fig. 5A, upper arrow, lanes 2–7). Protein
species of the same size also crosslinked to the control
pGEM RNA (Fig. 5A, lane 5). However, less protein bound
the pGEM RNA than the coronavirus-specific RNA tran-
scripts, consistent with the earlier preliminary filter-bind-
ing results, suggesting that N binds coronavirus RNAs
better than it binds heterologous RNAs (Cologna and
Hogue, 1998).
Western blotting was used to confirm that the slower-
FIG. 5. UV crosslinking/Western blotting of purified his-BCV N to RNA
ith purified, bacterially expressed his-tagged BCV N protein (lanes
ollowed by UV crosslinking, RNase treatment, and SDS–PAGE. Probes
protein was incubated in the absence (lane 1, both panels) or prese
filter-binding reactions. Half of each reaction that contained labeled p
was blotted onto nitrocellulose and the membrane was analyzed dire
antibodies (right panel).migrating species that crosslinked to the RNAs were
indeed his-BCV N. Filter-binding/UV crosslinking reac-tions were assembled with 32P-labeled Drep RNA and
his-tagged BCV N protein. After SDS–PAGE, gels were
blotted to nitrocellulose and analyzed by Western blot-
ting using N-specific antibodies, followed by autoradiog-
raphy (Fig. 5B, right and left panels, respectively). The
slower-migrating ;50-kDa crosslinked species and the
slowest-migrating higher-molecular-weight species (Fig.
5B, left panel, lane 3, arrows) were identified as N by
Western blotting, thus directly confirming that N binds
Drep RNA (Fig. 5B, right panel, lanes 1–3, arrows). The
sizes of the slower-migrating forms correspond to those
expected for dimer and trimer forms of N.
As a control, bacterially expressed his-tagged dihydro-
folate reductase (DHFR) was purified in parallel with
his-tagged BCV N and also used in the filter-binding/UV
crosslinking assay. This control clearly demonstrated
that no proteins in the molecular weight range of N
crosslinked to the RNAs (Fig. 5A, lanes 8–14). However,
the results also indicated that a bacterial contaminant
with an apparent molecular weight of ;15 kDa
crosslinked to some of the RNAs (Fig. 5, lower band in
lanes 3, 4, 6, 10, and 13). The contaminant was present in
the purified preparation of both his-BCV N and the DHFR
control protein, even though both appeared to be more
than 90% pure (data not shown). The heavily labeled
band that migrated above the bacterial contaminant in
lanes 3 and 10 of Fig. 5 is an RNase-resistant structure
that was consistently observed with the Drep probe.
P]-labeled RNA probes, as indicated above each lane, were incubated
DHFR protein (lanes 9–14) as described for filter-binding reactions,
1 and 8 were incubated in the absence of protein. (B) His-tagged BCV
[32P]-labeled Drep RNA (lanes 2 and 3, both panels) as described for
as UV crosslinked (lane 3, both panels). Following SDS–PAGE the gel
autoradiography (left panel) and by Western blotting using N-specific. (A) [32
2–7) or
in lanes
nce of
robe wAttempts to obtain purified his-tagged N protein prep-
arations that lacked the bacterial contaminant were not
240 COLOGNA, SPAGNOLO, AND HOGUEsuccessful. In addition to the copurification of the bacte-
rial protein, we also had other concerns about the bac-
terially expressed protein. The tagged N had been puri-
fied under denaturing conditions, and even though the
protein had been renatured, this raised concerns that the
protein might not be refolding into its native form. Also,
the protein was not phosphorylated when expressed in
bacteria (data not shown). The role of phosphorylation is
not known at this time; however, N is phosphorylated in
virus-infected cells and in virions. To circumvent these
problems, we chose to use infected cell lysates as the
source of N protein for the completion of our study.
Filter-binding reactions were initially set up using Drep
and pGEM RNA transcripts and both mock-infected and
BCV-infected HCT cell lysates. Filter-binding reactions
were assembled in double the normal volume. After
incubation half of each reaction was removed and ap-
plied directly to nitrocellulose filters. Filters were washed
and the amount of bound RNA was determined. The
other half of each reaction was immunoprecipitated with
N-specific polyclonal antibodies to recover N–RNA com-
plexes. This provided a measurement of the extent to
which N was associated with the RNAs that were de-
tected by direct filter binding.
Almost 60% of Drep RNA transcripts were retained on
filters after incubation with infected cell lysate, compared
with about 15% of the RNA that was incubated with
mock-infected lysate (Fig. 6A, Direct). Roughly 35% of the
Drep-infected lysate complexes were immunoprecipi-
tated with N-specific antibodies (Fig. 6A, IP). Therefore,
more than 60% of the Drep RNA that was retained by
direct filter binding was recoverable by immunoprecipi-
tation. The amount of pGem RNA retained by direct filter
binding with either lysate was similar to the amount of
Drep RNA retained by the binding of mock-infected cel-
lular proteins (Fig. 6A, Direct). Only background levels
(2–5%) of Drep RNA–protein complexes with mock-in-
fected lysate and pGEM RNA–protein complexes with
either lysate were immunoprecipitated with N-specific
antibodies (Fig. 6A, IP). These data demonstrated that
proteins in infected cell lysates bound the coronavirus
RNA better than they bound noncoronavirus RNAs. The
results clearly showed that the viral N protein was stably
associated with the majority of these RNA–protein com-
plexes.
We also directly visualized N-binding to Drep RNA. UV
crosslinking and Western blotting were performed fol-
lowing incubation of filter-binding reactions. N in BCV-
infected cell lysates, but not from mock-infected cells,
clearly bound Drep transcripts (Fig. 7A, lanes 2 and 3).
From our data we cannot absolutely rule out the pos-
sibility that other viral proteins also bound Drep RNA and
contributed to the increased filter binding with infected
cell lysates. From the UV crosslinking results none of the
major structural proteins (S, HE, or M) appeared to bind
Drep. We expect that some of the viral replicase proteinsmight also bind regions of the RNA that are involved in
RNA replication. However, these proteins are far less
abundant than the N protein and most likely would not be
detected by UV crosslinking.
To determine whether specific N-binding sites are
present within Drep, a series of transcripts were de-
signed to map sequences within the RNA that interact
with N. The maximum binding efficiency was measured
for each transcript by filter binding (Table 1). Maximum
N-binding efficiency was defined as the percentage of
RNA that was retained on the filter, compared to the total
amount of labeled RNA added to the reaction. Terminal
sequences, including the leader, Pol59, and BCV39NCR
were bound much less efficiently than was full-length
FIG. 6. Complex formation between N protein and defective genome
RNAs of BCV and MHV. Complexes between infected and mock-
infected lysate proteins and defective genome RNAs were detected by
filter binding. pGEM transcripts were analyzed in parallel as controls.
(A) Drep RNA was incubated with BCV-infected or mock-infected HCT
lysates. (B) MHV MIDI-C RNA was incubated with MHV-infected or
mock-infected 17Cl1 cell lysates. Half of each binding reaction was
filtered through nitrocellulose membranes and Cerenkov counted (A
and B, four left columns, Direct). The other half of each reaction was
immunoprecipitated with N-specific antibodies. Immunoprecipitated
N–RNA complexes were recovered with protein A–Sepharose and
counted (A and B, four right columns, IP). The data represent the means
of two and three experiments for MHV and BCV, respectively.Drep. The binding efficiencies for these transcripts were
similar to the nonviral RNAs pGEM and CAT. Transcripts
escribe
) and co
f molec
241CORONAVIRUS N–RNA INTERACTIONSN, N39, and N3939, all from within the N ORF, were bound
at efficiencies ranging from 57 to 73%. These binding
efficiencies were comparable to measurements for full-
T
Maximum BCV N Binding Effic
FIG. 7. UV crosslinking/Western blotting of N from infected cell lysates
were incubated with either BCV-infected (odd-numbered lanes) or
filter-binding reactions, followed by UV crosslinking, RNase treatmen
Membranes were analyzed directly by autoradiography (upper panel) a
were incubated in the absence of labeled probe in lanes 10 and 11. All
gel as a control for each reaction (data not shown). (B) [32P]-labeled M
mock-infected 17Cl1 cells (even-numbered lanes) and analyzed as d
Connected arrows indicate the position of crosslinked N (upper panels
single arrow in (A) notes the position of oligomeric N. The positions oa Mean percentage RNA bound 6 SD of three filtlength Drep. Other transcripts, N59 and N39 SpeI, also
from within the N ORF, were bound less efficiently at 22
and 12%, respectively. Only low-level binding was ob-
s for Drep and Related RNAs
s. (A) [32P]-labeled BCV RNA transcripts, as indicated above each lane,
nfected (even-numbered lanes) HCT cell lysates as described for
SDS–PAGE. After SDS–PAGE gels were blotted onto nitrocellulose.
estern blotting using N-specific antibodies (lower panel). Cell lysates
were incubated in the absence of protein and analyzed on a parallel
nscripts were incubated with MHV-infected (odd-numbered lanes) or
d above. Lysates in lanes 2 and 3 were not incubated with probe.
rresponding position detected by Western blotting (lower panels). The
ular weight standards are indicated at the left of each panel.ABLE 1
iencieto RNA
mock-i
t, and
nd by W
probes
HV traer-binding experiments for each RNA.
Each d
242 COLOGNA, SPAGNOLO, AND HOGUEserved for all RNAs using mock-infected lysates (data
not shown). Taken all together, the data indicated that a
high-efficiency N-binding sequence is located within the
39 terminal 434 nucleotides of the N ORF.
To directly demonstrate N-binding to the regions that
exhibited the highest-efficiency binding, UV crosslinking
and Western blotting were performed on filter-binding
reactions. N bound the high-efficiency binding transcript
N3939 that mapped at the 39 end of the N ORF (Fig. 7A,
lanes 8 and 9). However, N was not crosslinked to the
Drep fragment N39 SpeI that was retained on filters
comparably to the noncoronavirus RNAs (Fig. 7A, lanes 6
and 7), thus directly demonstrating that N accounts for
the increased binding observed over the background
binding of cellular proteins.
We recently showed that a region of the BCV genome
shares homology with the packaging signal of MHV and
demonstrated that it is a functional packaging signal
(Cologna and Hogue, 2000). Even though Drep does not
contain this region of the genome, we also measured
N-binding to this RNA to compare it with the binding data
for Drep. About 37% of the BCV pkg transcripts were
bound by N, indicating that N interacts with the packag-
ing signal, but interestingly, not as efficiently as with a
region of the N ORF. UV crosslinking and Western blot-
FIG. 8. Nitrocellulose filter binding of proteins from BCV- and MHV-in
lysate (A), MHV-infected 17Cl1 lysate (C), mock-infected HCT lysate (B
genome RNAs and a transcript containing the MHV packaging signal.
depict the standard deviation of the means.ting confirmed that N bound the packaging signal-con-
taining transcript (Fig. 7A, lanes 4 and 5).Both MHV-A59 N and BCV N bind MIDI-C at a higher
efficiency than does Drep
As we mapped the N-binding regions within Drep, we
wanted to determine how the high-efficiency binding
region within the N ORF compared with efficiency of
N-binding to the MHV packaging signal. The MHV DI
genome MIDI-C was used for this analysis. At the time
these measurements were made, we had not identified
the BCV genomic packaging signal. The rationale for our
interest in comparing N-binding to MHV and BCV RNAs
was discussed earlier. MIDI-C contains a known pack-
aging signal, and MHV and BCV are closely related, but
distinct viruses.
Initially we used mock-infected and both BCV- and
MHV-A59-infected cell lysates to compare the RNA-bind-
ing efficiencies of MIDI-C, Drep, and the MHV packaging
signal (Fig. 8). BCV- and MHV-infected lysates were com-
pared to rule out the possibility that differences in the N
proteins from the respective viruses might affect N–RNA
interactions (Figs. 8A and 8B, respectively). The binding
efficiencies for the RNA transcripts were essentially the
same for both lysates. The binding efficiencies for all
RNAs were much lower when mock-infected lysates
from either HCT (Fig. 8B) or 17Cl1 (Fig. 8D) cells were
ysates to BCV and MHV RNAs. Different amounts of BCV-infected HCT
Cl1 lysate (D) were incubated with labeled BCV- and MHV-defective
ata point represents the average of three experiments. The error barsfected l
), or 17used. The results demonstrated that N interacts with
Drep similar to the interactions of N with the MHV pack-
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243CORONAVIRUS N–RNA INTERACTIONSaging signal. The higher level of MIDI-C retention
strongly suggested that N might bind other sites in ad-
dition to the 69-nt packaging signal within the RNA.
We confirmed that MHV N protein was associated with
the majority of the MIDI-C RNA retained by direct filter
binding as described above for BCV. Approximately 60%
of MIDI-C RNA was retained by direct filter binding in the
presence of MHV-infected cell lysates. About 40% of the
retained protein–RNA complexes were recovered by im-
munoprecipitation, thus indicating that at least 67% of the
MIDI-C RNA was associated with N (Fig. 6B). Only back-
ground levels of RNA were recovered by immunoprecipi-
tation when infected lysates were used as the source of
protein or when the control pGem RNA was incubated
with either lysate (Fig. 6B).
The MHV packaging signal is not required for high-
efficiency binding of MIDI-C
The difference in binding efficiencies between MIDI-C
and its packaging signal led us to extend our mapping
analysis of the DI. Maximum binding efficiencies were
measured for a series of MIDI-C-deletion transcripts
using MHV-infected cell lysates (Table 2). Binding effi-
ciencies for 39 terminal deletions MIDI-C MluI and
IDI-C SpeI were comparable to the binding efficiency
or intact MIDI-C RNA. Interestingly, the MIDI-C SpeI
T
Maximum MHV N Binding Effici
a Mean percentage RNA bound 6 SD of three filranscript lacked the MHV packaging signal. A shorter
ranscript, MIDI-C EcoRI, from approximately 1.3 kb of the
(
d9 end of MIDI-C, exhibited a significantly lower maxi-
um N-binding efficiency when compared to that of
ull-length MIDI-C. The binding for the ;1.3-kb transcript
as similar to measurements for MHV pkg, the RNA
ranscript containing the packaging signal. We also in-
luded a transcript of the MHV N ORF in our mapping
nalysis since we had identified the high-efficiency bind-
ng site within the BCV N ORF, as described above. The
HV N transcript had a binding efficiency similar to the
HV pkg RNA. Binding, like that for BCV, mapped to the
9-most region of the MHV N ORF.
To further map the binding region within the polymer-
se 1a region, a fragment (nts 461–3689) of MIDI-C was
ubcloned and used to generate four transcripts that
ncompassed this region. The MHV59 SalI transcript
ound N as efficiently as MIDI-C RNA. Shorter tran-
cripts, MHV59 NspV and MHV59 HindIII, exhibited
lightly reduced levels of N-binding, compared to those
f MIDI-C. Binding was greatly reduced for MHV59 AflII
92-nt transcript. This indicated that a high-efficiency
inding site maps between the AflII and HindIII sites (nts
35–1986).
N-binding to full-length MIDI-C, the 59 HindIII region
rom gene 1a, the MHV packaging signal and the 39
nd of the N ORF was demonstrated directly by UV
rosslinking and Western blotting as described earlier
for MIDI-CC and Related RNAs
ing experiments for each RNA.ABLE 2
enciesFig. 7B, lanes 4–9 and 12 and 13). No N binding was
etected with the N 5939 ;400-nt transcript from the N
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244 COLOGNA, SPAGNOLO, AND HOGUEORF in MIDI-C that exhibited only background binding
when analyzed by filter binding (Fig. 7B, lanes 10 and
11).
Collectively, the mapping data for MIDI-C demonstrate
that at least three N binding sequences are located in
MIDI-C. One maps to a region that includes the packag-
ing signal (nts 3949–4524), a second signal is located in
the N ORF (nts 4837–5197), and another within an ap-
proximately 1-kb region of the polymerase 1a region (nts
935–1986).
The high-efficiency N-binding region within the BCV N
ORF does not function as a packaging signal
The presence of a single high-efficiency binding site
within the BCV N ORF was consistent with our initial
hypothesis that a packaging signal located within the
gene might account for packaging of Drep, and possibly
subgenomic RNAs in BCV virions. To test this hypothesis,
experiments were performed as we recently described
for the identification of a BCV packaging signal (Cologna
and Hogue, 2000). The 39 N gene region was subcloned
59 to the chloramphenicol acetyltransferase (CAT) gene
that contained the hepatitis delta virus ribozyme and T7
terminator at its 39 end. The BCV packaging signal ap-
pended at the 59 end of the CAT-ribozyme-T7 terminator
cassette and CAT-ribozyme-T7 terminator construct were
used as positive and negative controls, respectively (Co-
logna and Hogue, 2000). In addition the CAT-ribozyme-
terminator cassette was subcloned downstream of full-
length Drep to generate pDrepE-CAT.R.
All plasmid constructs were expressed in BHK cells
using the vaccinia recombinant vTF7-3 (Fuerst et al.,
1986), followed by infection with BCV as we described
previously (Cologna and Hogue, 2000). Extracellular BCV
virions were collected at 24 h after infection with BCV.
Both intracellular and RNase-treated, purified virion RNA
were analyzed by Northern blotting with a probe specific
for Drep. The results demonstrated that the 39 region of
the N ORF RNA was not sufficient to target CAT for
packaging extracellular BCV virions (Fig. 9, lanes 6 and
16). Surprisingly, the entire Drep RNA also did not target
CAT for packaging (Fig. 9, lanes 5 and 15). Implications of
these observations are discussed below.
DISCUSSION
This study demonstrates for the first time that N inter-
acts with both genomic and subgenomic RNAs in BCV-
infected cells. N–viral RNA complexes were previously
shown to be present in cells infected with MHV, a virus
that is closely related to BCV (Baric et al., 1988). Since the
iral leader is common to genomic and subgenomic
NAs, the earlier study suggested that interactions be-
ween the leader and N could explain the presence of
hese complexes in virus-infected cells (Baric et al.,
988). N-binding to coronavirus leader RNA supports thisdea (Stohlman et al., 1988). Recent biochemical analysis
easured a dissociation constant (K d) of 14 nM for bac-
erially expressed MHV N-binding to the leader RNA
Nelson et al., 2000). We also found that N interacts in
vitro with both BCV and MHV leader RNAs in the pres-
ence of excess nonspecific competitor RNA. Complexes
consisting of N and small leader-containing RNAs are
present in MHV-infected cells (Baric et al., 1988). We
have also immunoprecipitated small (.100 nt) N–leader
containing RNA complexes from BCV-infected cells (Co-
logna and Hogue, unpublished data).
Taken all together the results from these studies sug-
gest that N–RNA complexes are conserved structures in
coronavirus-infected cells. Conservation of such com-
plexes argues in support of the idea that N–RNA inter-
actions play important roles in viral transcription, trans-
lation, and/or replication (Nelson et al., 2000). Our results
suggest that interactions between N and the N ORF, a
region that is also common to all of the viral RNAs, may
contribute, in addition to interactions with the leader, to
the formation of the N–RNA complexes that are present
in coronavirus-infected cells. Previous studies sug-
gested that N binds nonspecifically to RNA. (Robbins et
al., 1986; Masters, 1992). Our data clearly demonstrate
that N binds noncoronavirus and coronavirus RNAs both
in vivo and in vitro; however, the protein interacts more
efficiently with the latter.
A major goal when we initiated this study was to
identify the signal(s) responsible for packaging of the
BCV-defective genome Drep. We were particularly inter-
ested in this since the defective genome lacks the pack-
FIG. 9. Northern blot analysis of chimeric RNA transcripts packaged
by BCV. Plasmid DNAs (lanes 2–7, 9 and 10, 12–17, and 19 and 20) were
transfected into vTF7-3-infected cells (all lanes). 1BCV denotes cells
that were infected with BCV following transfection (lanes 5–9 and
15–19). Both intracellular RNAs (lanes 1–10) and extracellular virion
RNAs (lanes 11–20) were analyzed by Northern blotting with a CAT-
specific probe. Extracellular media were treated with DNase and
RNase prior to isolation of virions. Cells were infected only with vTF7-3
and mock-transfected in lanes 1 and 11.aging signal that we subsequently identified within the
BCV genome and because BCV packages subgenomic
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245CORONAVIRUS N–RNA INTERACTIONSRNAs in addition to genomic RNA (Hofmann et al., 1990;
Chang et al., 1994; Cologna and Hogue, 2000). We
mapped one high-efficiency N-binding region in the 39
half of the N ORF within Drep RNA. However, a nonviral
RNA that contained the N-binding region was not pack-
aged, suggesting that interactions between N and this
region of the RNA do not explain why Drep or subgenom-
ics are packaged by BCV. Even though the high-effi-
ciency binding region does not appear to be directly
relevant for packaging, interactions between N and this
region of the genome may play a role indirectly in the
assembly of the helical nucleocapsid. Interestingly we
also mapped a high-efficiency N-binding site within the
39 half of the MHV N ORF. N presumably binds multiple
regions throughout the genomic RNA. High-efficiency
N-binding sites, other than the packaging signal, may
contribute to the efficiency of packaging, while not being
a functional packaging signal.
Surprisingly, when Drep was expressed as part of a
chimeric CAT RNA transcript, the RNA was also not
packaged by BCV. We cannot rule out the possibility that,
if Drep contains a packaging signal, the folding of the
chimeric RNA masked it. It is also possible that the
defective genome must be replicated subsequent to or
concurrent with packaging. Preliminary data in our lab
support the idea that replication and packaging may be
coupled, and experiments are ongoing to address this.
Different maximum N-binding efficiencies were mea-
sured for Drep and MIDI-C, defective genomes for BCV
and MHV, respectively. We were able to calculate only
rough estimates for K ds since our his-tagged N protein
preparations were not absolutely pure. Analysis of our
data for N-binding to MIDI-C and Drep RNAs yielded K ds
f ;21 and ;89 nM, respectively. The K d for N binding to
noncoronavirus transcripts was ;1 mM. The differences
in binding activity for MIDI-C and Drep may have impor-
tant implications for the comparative efficiency with
which the two defective genomes are encapsidated and
packaged.
Packaging signals have been identified for both MHV
and BCV (van der Most et al., 1991; Fosmire et al., 1992;
Cologna and Hogue, 2000). Intuitively one might expect a
packaging signal to exhibit the highest N-binding when
compared to other parts of the genome. However, this is
not the case for MIDI-C, at least under the in vitro
conditions used in our study. N bound as efficiently to
MIDI-C RNA when the packaging signal was deleted as
it did to MIDI-C that contained the packaging signal.
Molenkamp and Spaan (1997) initially showed that N
binds the MHV packaging signal, but binding affinities
were not measured and N-binding sites were not
mapped for other regions of MIDI-C. We measured a K d
of ;100 nM for N-binding to an ;600-nt transcript that
ncluded the MHV packaging signal. At this time it is not
lear what distinguishes other N-binding sites within the
enome from N-binding to the packaging signal. Under Bthe in vitro assay conditions used here it appears that
inding efficiency might not be the determining factor.
owever, the context within which the signal is pre-
ented within the genome may alter the interactions,
ven though the packaging signal alone is sufficient to
irect an RNA to be packaged in either MHV- or BCV-
nfected cells (Bos et al., 1997; Woo et al., 1997; Cologna
nd Hogue, 2000).
The packaging signal by itself may not determine the
fficiency of genomic RNA packaging. Bos and col-
eagues (1997) inserted an intergenic sequence into
HV MIDI-C to direct the synthesis of a subgenomic
NA containing the MHV packaging signal; the sub-
enomic was packaged less efficiently than the parental
IDI genomic RNA. This suggests that other factors may
e involved in determining the efficiency of packaging.
hese elements could be a specific sequence(s) or
tructure(s) that functions as a packaging enhancer by
inding N and allowing the RNA to be more efficiently
ncapsidated and packaged into mature virions. The
lement(s) within gene 1a that we identified are possibly
mportant in this regard. We are currently testing this
ossibility. Sequences that enhance packaging have
een identified for other viruses. For example, naturally
ccurring Sindbis virus DI RNAs contain a sequence at
he 59 end that enhances packaging (Frolova et al., 1997).
Our data suggest that both monomeric and oligomeric
orms of N interact with RNA. These interactions may be
mportant for the assembly of the encapsidated RNA,
ince it is logical to think that N–N interactions occur in
he helical nucleocapsid. Trimeric forms of N associated
ith both MHV and BCV virions were previously noted
Hogue et al., 1984; Robbins et al., 1986). In vitro interac-
ions between N monomers were recently reported
Wang and Zhang, 1999), which is consistent with the
bility of N to form multimers associated with RNA. Our
ata are the first to directly show that oligomers of N bind
NA.
Packaging signals have been identified for a number
f viruses, and NC–RNA interactions have been studied
or some of these. The Sindbis capsid protein specifically
inds with high affinity to a 132-nt region within the viral
NA genome that is a functional packaging signal (Weiss
t al., 1994). The NC protein of human immunodeficiency
irus type 1 (HIV-1) binds specifically to several stem
oops near the 59 end of the genome that constitute a
ackaging signal. The NC has an apparent K d of about
200 nM for the individual stem loops or 50 nM for the
group of stem loops (Clever et al., 2000).
Interactions between nucleocapsid proteins and RNA
for other viruses with helical nucleocapsids have been
studied; however, extensive mapping as we describe
here has not been done. Influenza virus nucleoprotein
NP appears to bind the viral RNA backbone without
apparent sequence specificity (Yamanaka et al., 1990;
audin et al., 1994). Binding affinity for segment 8 viral
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246 COLOGNA, SPAGNOLO, AND HOGUERNA (vRNA), conserved 59 and 39 ends of the vRNAs, and
egenerate sequences were all bound at similar affini-
ies with K ds that ranged from 20 to 38 nm. The affinity of
vesicular stomatitis virus (VSV) N protein for leader RNA
that contains the VSV encapsidation signal is ;10 times
higher than that for nonspecific sequences (Blumberg et
al., 1983). The results presented here indicate that coro-
navirus N, like influenza virus NP, does not exhibit abso-
lute specificity for only coronavirus RNAs. However, the
protein does appear to preferentially bind coronavirus
RNAs. Furthermore, N binds certain regions of the viral
RNAs better than others. Binding specificity for encapsi-
dation and packaging in the context of virus-infected
cells may be influenced by interactions with the mem-
brane (M) protein or possibly other viral proteins. Com-
partmentalization of replication complexes in membra-
nous structures may also provide an environment that
eliminates the necessity for absolute N-binding specific-
ity.
MATERIALS AND METHODS
Viruses and cell lines
The human adenocarcinoma ileocecal cell line HCT-8
was maintained in Dulbecco’s modified Eagle’s medium
(DMEM). Baby hamster kidney (BHK-21) cells were
grown in Glasgow minimal essential medium (GMEM).
Both cell lines were obtained from ATCC (Rockville, MD).
Mouse 17 clone 1 (17Cl1) cells were propagated in
DMEM. All media were supplemented with 10% fetal
bovine serum (FBS). Plaque-purified bovine enteric coro-
navirus (BCV) Mebus strain virus stock was grown and
titered on HCT-8 cells as previously described (Nguyen
and Hogue, 1997). The MHV-A59 virus strain was grown
on 17Cl1 cells and titered on 17Cl1 and DBT cells. The
vTF7-3 recombinant vaccinia virus expressing T7 RNA
polymerase (Fuerst et al., 1986) virus stock was grown on
HeLa cells and titered on CV-1 and BS-C-1 cells.
Plasmids
Coronavirus-defective genomes, pDrep (Chang et al.,
1994), and pMIDI-C (van der Most et al., 1991) were
obtained from David Brian (University of Tennessee–
Knoxville) and Willy Spaan (Leiden University, The Neth-
erlands), respectively. Convenient restriction sites, PCR
amplification, and standard methods for DNA manipula-
tion were used to generate fragments of the defective
genomes (Fig. 1, Tables 1 and 2). All fragments were
subcloned into pGEM-3Zf(1) (Promega, Madison, WI). All
PCR products were confirmed by sequencing.
All N fragments were generated from plasmid pB-
CVN4.1. Plasmid pBCVN4.1 contains the entire N gene
derived from the original MA7 cDNA genomic clone
(Lapps et al., 1987). The clone contains 8 nts 59 to the
start codon and 24 nts following the stop codon. Plasmid
D
[pPol was created by PCR amplification of nucleotides 98
to 472 from the polymerase region of pDrep. BamHI and
EcoRI sites were included in the PCR product at the 59
and 39 ends of the coding sequence, respectively. Plas-
mid pBCVN59 was created by subcloning the EcoRI/BglII
fragment from pBCVN4.1 into EcoRI/BamHI restricted
vector. The BglII/HindIII fragment of pBCVN4.1 was sub-
cloned into BamHI/HindIII cut vector to construct plas-
mid pBCVN39. Plasmid pBCVN3939 was generated by
subcloning the SpeI/HindIII fragment of pBCVN39 into
XbaI/HindIII cut vector. Plasmid pBCVpkg was previously
described (Cologna and Hogue, 2000). The 59 end of the
BCV gene 1a was subcloned from Drep by PCR amplifi-
cation. Construction of pBCV39NCR was previously de-
scribed (Spagnolo and Hogue, 2000). Plasmid pBCVN4
contains the entire N gene as described above for pB-
CVN4.1 that was modified to contain a hepatitis delta
ribozyme and T7 terminator. This was accomplished by
subcloning a fragment that contains both elements from
plasmid v2.0 (Pattnaik et al., 1992) at the 39 end of the N
ORF.
Plasmid DrepE-CAT.R was generated by introduction
of an EcoRI site at the 59 end of Drep and subcloning of
a cassette that contained the CAT gene, the hepatitis
delta virus ribozyme, and the T7 terminator at the 39 end.
The other chimeric constructs (BN39-CAT.R, Bpkg-CAT.R,
and pGEM-CAT.R) and the CAT cassette were all previ-
ously described (Cologna and Hogue, 2000).
Plasmid pMHVpkg was constructed by PCR amplifica-
tion of a fragment encompassing nucleotides 3941 to
4529 from pMIDI-C. The PCR strategy introduced an
EcoRI site at the 59 end of the coding sequence and a
BamHI site at the 39 end for subcloning purposes. Plas-
mid pMHVN1 that includes the entire MHV A59 N gene,
plus 6 nt 59 to the start codon and 16 nt from the 39
noncoding region sequences, was PCR-amplified from
plasmid pA50 (Masters, 1992). KpnI and XbaI sites were
introduced during amplification at the 59 and 39 ends of
the MHV N coding sequence, respectively. Plasmid
pMHV N59 was generated by subcloning the 59 EcoRI/
NheI fragment from pMHVN and subcloning into EcoRI/
XbaI cut vector. The internal NheI/EcoRI 405 nt fragment
from pMHVN was subcloned into EcoRI/XbaI cut vector
o create pMHV ND5939. Plasmid pMHVN was restricted
ith EcoRI and the 3.5-kb fragment, which included all of
he vector plus 382 nt from the 39 end of the N gene, was
solated and religated to make pMHV N39.
Plasmid pNAR1 was generated by subcloning the
maI/HindIII fragment from v2.0 (Pattnaik et al., 1992) into
maI/HindIII restricted pNA (Brown et al., 1988).
reparation of RNA transcripts
Convenient restriction sites were used to linearize
NAs for in vitro transcription of both unlabeled and
a32P]CTP-labeled transcripts that were used for filter
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247CORONAVIRUS N–RNA INTERACTIONSbinding. Transcripts contained 0–38 nt and 0–30 nt at the
59 and 39 termini, respectively. These exogenous nucle-
otides were encoded by restriction sites retained from
the multiple cloning region of pGEM-3Zf(1) during sub-
cloning. Vector pGEM-3Zf(1) (Promega) that had been
cut with ScaI was used to generate runoff of an ;1.8-kb
ranscript as a noncoronavirus control. All positive-sense
ranscripts, with the exception of BCV pPol and pM-
VND5939 that were transcribed from the SP6 promoter,
ere generated from the T7 promoter. Unlabeled RNAs
ere transcribed using either Promega or Megascript
Ambion, Austin, TX) reagents according to the manufac-
urer’s protocols. Unlabeled RNAs were monitored on
ondenaturing agarose gels stained with ethidium bro-
ide and quantitated by standard absorbance readings
t A260. DNA templates were removed by digestion with
DNase following transcription. Free nucleotides were
removed from labeled transcripts using micro Bio-Spin
columns (Bio-Rad, Richmond, CA), which has been
washed extensively with RNase-free water. RNAs were
monitored on nondenaturing agarose gels stained with
ethidium bromide. RNAs were quantified and specific
activity was calculated using standard protocols.
Capped Drep and MIDI-C RNAs for defective genome
replication and packaging studies were generated using
T7 MEGAscript kit (Ambion) following the manufacturer’s
protocol. RNAs were precipitated following DNase treat-
ment and quantified by absorbance at 260 nm; integrity
was monitored by electrophoresis on agarose gels and
ethidium bromide staining.
Generation of N-specific polyclonal antibodies
A histidine-tagged BCV N fusion protein was ex-
pressed and purified from bacteria as previously de-
scribed (Cologna and Hogue, 1998). Six histidine resi-
dues replaced the first 17 amino acids at the amino-
terminus of the BCV N protein. Two female New Zealand
White rabbits were inoculated with the purified his-
tagged N protein using standard protocols (Harlow,
1988). Antibodies were purified by selection over a pro-
tein A column (Bio-Rad) as recommended by the manu-
facturer. Western blotting and immunoprecipitations de-
termined the specificity of the antibodies.
Detection of RNAs associated with N during a BCV
infection by agarose gel electrophoresis
Subconfluent monolayers of HCT cells were infected
with BCV at a multiplicity of infection (m.o.i.) of 10. After
infection cells were incubated in DMEM containing 2%
FBS. At 4 h postinfection (p.i.), cells were labeled with
[32P]orthophosphate (200 mCi/ml) for 4 h in phosphate-
ree DMEM containing 5% FBS that had been dialyzed.
ne dish of mock- and BCV-infected cells was labeled in
he presence of 2 mg/ml actinomycin D to specifically
label only viral RNAs. Total cytoplasmic RNA was iso-lated from cells at 8 h p.i. with TRIzol (Life Technologies,
Gaithersburg, MD). To isolate N-associated RNAs, cells
were washed with cold PBS and lysed in immunoprecipi-
tation (IP) lysis buffer (10 mM Tris–HCl [pH 7.4], 100 mM
NaCl, 20 mM EDTA, 5 mM MgCl2, 0.5% Triton X-100, 0.5%
sodium deoxycholate [DOC], 1 mM PMSF, and 10 mM
iodoacetamide). Nuclei and cell debris were removed by
centrifugation at 4°C for 10 min at 13,000 g. Lysates were
immunoprecipitated with either preimmune serum, puri-
fied 1383 anti-N rabbit polyclonal antibodies, or a mix of
monoclonal anti-BCV S ascites antibodies (HB10-4,
JB5-6, and HF8-8) (Deregt and Babiuk, 1987). Protein
A–Sepharose-bound immune complexes were washed
three times in IP lysis buffer supplemented with 0.1%
SDS. Protein–RNA complexes were eluted in 50 ml of
lution buffer (10 mM Tris–HCl [pH 7.4], 50 mM NaCl, 1
M EDTA, 200 mg/ml yeast tRNA, and 1.0% SDS). RNAs
were extracted with TRIzol (Life Technologies), washed
with 70% ethanol, and air-dried. Standard conditions for
denaturing and electrophoreses on 1% agarose gels
containing 2.2 M formaldehyde were followed. The gels
were washed extensively with RNase-free water, dried,
and autoradiographed.
Isolation of N–RNA complexes formed during vaccinia
expression and Northern blot analysis
Subconfluent BHK-21 cells were infected with vTF7-3
(Fuerst et al., 1986) at a m.o.i. 5 10 for 1 h in GMEM and
ransfected essentially as previously described (Nguyen
nd Hogue, 1997). Following infection, cells were trans-
ected with a total of 15 mg of pNA.R1 or pBCVN4.1 DNA
using 15 ml of Lipofectin (Life Technologies). Cells were
harvested 16 h p.i. in IP lysis buffer as described above.
The lysates were divided into three aliquots. One aliquot
was extracted for total RNA and the other two aliquots
were immunoprecipitated with either purified 1383
anti-N rabbit antibodies or anti-NA peptide polyclonal
serum (Hogue and Nayak, 1992). Total RNA samples
were treated with RQ1-RNase-free DNase. N–RNA and
NA–RNA complexes were immunoprecipitated as de-
scribed above. RNAs were denatured, electrophoresed
on a 1% agarose gel in the presence 2.2 M formaldehyde,
transferred to NitroBind membrane (Amersham Pharma-
cia Biotech, Piscataway, NJ) by vacuum transfer, and
probed with either a BCV N gene-specific or an influenza
NA gene-specific riboprobe uniformly labeled with
[a-32P]CTP.
n-solution binding assay
The in-solution binding assay was carried out essen-
ially as described previously (Geigenmuller-Gnirke et
l., 1993). In vitro transcribed, nonlabeled RNAs were
incubated with in vitro translated [35S]methionine-labeled
N protein in a binding buffer that consisted of 10 mM
Tris–HCl (pH 7.4), 100 mM NaCl, 1 mM EDTA, 1 unit
r0
e
a
3
g
P
h
c
m
v
b
H
a
E
w
o
q
c
B
l
F
2
7
5
i
t
p
248 COLOGNA, SPAGNOLO, AND HOGUERNasin, and 5 mg of BHK total cytoplasmic RNA. Total
eaction volume was 10 ml. The amount of translated N
included in each reaction varied from 0.2 to 5 ml and was
determined by the extent of incorporation of [35S]methi-
onine during translation. Reactions were incubated for
20 min at room temperature and 2 ml of dye (20% Ficoll,
.05% bromophenol blue in 0.253 TBE) was added to
ach reaction before loading on a 1% nondenaturing
garose gel in 0.253 TBE. Gels were electrophoresed at
0 mA for 4 h, soaked in methanol, dried, and autoradio-
raphed.
reparation of cell lysates
HCT cells were infected with BCV at a m.o.i. of 5 and
arvested at 16 h after infection. MHV-A59-infected 17Cl1
ells were harvested 12 h p.i. Mock-infected cells were
aintained and prepared in parallel. Cells were har-
ested by washing twice with ice-cold PBS and washing
riefly with 13 hypotonic buffer containing 10 mM Tris–
Cl (pH 7.4), 10 mM NaCl, 1 mM PMSF, 10 mM iodo-
cetamide, and 13 proteinase-inhibitor cocktail minus
DTA (Boehringer Mannheim, Indianapolis, IN). Cells
ere scraped into 0.53 hypotonic buffer and incubated
n ice for 10 min before Dounce homogenization. Ali-
uots of the lysates were stored at 280°C. Protein con-
entrations were determined for each lysate using the
CA Protein Assay (Pierce, Rockford, IL). Cytoplasmic
ysates were stable for about 1 month.
ilter-binding assay
Filter-binding reactions were carried out in a volume of
0 ml. Reaction buffer consisted of 10 mM Tris–HCl (pH
.4), 1 mM DTT, 1 mM EDTA, 250 mM NaCl, 1 unit RNasin,
.0 mg BHK total cytoplasmic RNA, and 10 mg heparin.
Cytoplasmic lysates or purified proteins (0.5–10 mg) were
ncubated with 0.1 nM of labeled RNA for 20 min at room
emperature. Reaction mixtures were filtered through
rewetted 0.45-mm-pore-size nitrocellulose filters,
washed twice with ice-cold wash buffer (10 mM Tris–HCl
[pH 7.4], 100 mM NaCl, and 1 mM EDTA) and air-dried.
Only RNA complexed with protein was retained on the
filters and was detected by Cerenkov counting. The total
amount of radioactivity added to each reaction was de-
termined by spotting 0.1 nM of labeled RNA probe onto
nitrocellulose filters and Cerenkov counting. The per-
centage of RNA retained on filters was calculated using
the following formula: %RNA 5 (cpm retained on filter per
reaction/total cpm added to the reaction) 3 100.
UV crosslinking/Western blotting
Filter-binding reactions were assembled as described
above. After incubation reactions were placed on ice and
UV-irradiated at 254 nm (UV Stratalinker; Stratagene, La
Jolla, CA) at a distance of 10.5 cm for 30 min. After
crosslinking, 1 mg RNase A and 10 units RNase T1 wereadded to each reaction. Reactions were incubated for 15
min at 37°C. SDS–PAGE sample buffer was added to the
reactions. Samples were heated at 95°C before being
resolved by SDS–PAGE. Following electrophoresis gels
were electroblotted to nitrocellulose membranes. West-
ern blots were probed with rabbit anti-N antibodies,
followed by goat anti-rabbit secondary IgG conjugated to
alkaline phosphatase.
N–RNA complex immunoprecipitation
For immunoprecipitation of N–RNA complexes, filter-
binding reactions were assembled as described above.
After incubation half of each reaction was analyzed di-
rectly for retention of RNA on filters. The other half of
each reaction was incubated with purified N-specific
antibodies (rabbit 1383) for 30 min on ice, followed by
incubation with protein A–Sepharose for 1 h. Immuno-
precipitates were washed three times with filter-binding
wash buffer. N–RNA complexes bound to protein
A–Sepharose were analyzed by Cerenkov counting. The
percentage of RNA immunoprecipitated was calculated
using the formula: %RNA IP 5 (cpm bound to protein
A–Sepharose/half of the cpm added to binding reac-
tion) 3 100.
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